Skip to main content
Log in

In Vitro and in Vivo Transport of Zidovudine (AZT) Across the Blood–Brain Barrier and the Effect of Transport Inhibitors

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The transport of the antiviral nucleoside analogue zidovudine (3′-azido-3′-deoxythymidine; AZT) into the central nervous system (CNS) was characterized in vitro and in vivo. The in vitro model consisted of primary cultures of isolated bovine capillary endothelial cells. The transport rate of AZT across the monolayer, expressed as endothelial permeability P, was determined following luminal and abluminal administration. P did not differ between the two administration sites (luminal, 1.65 ± 0.44 cm/min/103; abluminal, 1.63 ± 0.28 cm/min/103). The transport of AZT across the endothelial cell monolayer was found to be concentration independent in the range between 0.4 and 50 µg/mL. AZT transport was not affected by pre-treatment of the cells with either metabolic inhibitors (DODG and DODG/NaN3) or probenecid. This suggests that AZT passes the monolayer mainly by passive diffusion. The in vivo transport of AZT across the blood–brain barrier and the blood–CSF barrier was studied in male Wistar rats after coadministration of potential inhibitors of active transport of AZT: probenecid (organic anion transport) and thymidine (nucleoside transport). Intracerebroventricular and intravenous coadministration of probenecid caused a significant (P < 0.001) increase in the CSF/plasma concentration ratio compared to the control phase, indicating that the organic anion carrier is involved in AZT transport from CSF to blood. Since there was no effect of probenecid on the transport of AZT in vitro, it is suggested that this carrier is located at the choroid plexus. Coadministration of thymidine did not affect the CSF/plasma concentration ratio, suggesting that a nucleoside carrier system is not involved in AZT transport into or out of the CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. Yarchoan and S. Broder. Antiretroviral therapy of AIDS and related disorders: General principles and specific development of dideoxynucleosides. Pharmacol. Ther. 40:329–348 (1989).

    Google Scholar 

  2. R. Yarchoan, H. Mitsuya, C. E. Myers, et al. Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N. Engl. J. Med. 321:726–738 (1989).

    Google Scholar 

  3. M. A. Fischl. State of antiretroviral therapy with zidovudine. AIDS 3 (Suppl. 1):S137–S143 (1989).

    Google Scholar 

  4. L. Resnick, J. R. Berger, P. Shapshak, et al. Early penetration of the blood-brain barrier by HIV. Neurology 38:9–14 (1988).

    Google Scholar 

  5. R. M. Levy, D. E. Bredesen, and M. L. Rosenblum. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature. J. Neurosurg. 62:475–495 (1985).

    Google Scholar 

  6. R. W. Price, B. Brew, J. Sidtis, et al. The brain in AIDS: Central nervous system HIV-I infection and AIDS dementia complex. Science 239:586–592 (1988).

    Google Scholar 

  7. C. Pedersen, C. Thomsen, P. Arlien-Soborg, et al. Central nervous system involvement in human immunodeficiency virus disease. Dan. Med. Bull. 38 (4):374–379 (1991).

    Google Scholar 

  8. P. Portegies, J. De Gans, J. M. A. Lange, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br. Med. J. 299:819–821 (1989).

    Google Scholar 

  9. R. E. Galinsky, B. L. Hoesterey, and B. D. Anderson. Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection. Life Sci. 47:781–788 (1990).

    Google Scholar 

  10. A. R. Rachlis. Zidovudine (Retrovir) update. Can. Med. Assoc. J. 143 (11):1177–1185 (1990).

    Google Scholar 

  11. J. B. M. M. Van Bree, A. G. de Boer, M. Danhof, et al. Characterization of an “in vitro” blood-brain barrier: Effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. J. Pharmacol. Exp. Ther. 3:1233–1239 (1988).

    Google Scholar 

  12. J. B. M. M. Van Bree, A. V. Baljet, A. Van Geyt, et al. The unit impulse response theory for the pharmacokinetic evaluation of drug entry into the central nervous system. J. Pharmacokin. Biopharm. 17:441–462 (1989).

    Google Scholar 

  13. K. L. Audus and R. T. Borchardt. Characterization of an in vitro blood-brain barrier model for studying drug transport and metabolism. Pharm. Res. 3:81–87 (1986).

    Google Scholar 

  14. J. B. M. M. Van Bree, D. L. Ypey, A. G. De Boer, et al. Trans-endothelial electrical resistance (TEER) of an in vitro blood-brain barrier: An indicator of drug permeability? (Submitted for publication).

  15. W. C. Bowman and M. J. Rand. Drug treatment of viral infections. In W. C. Bowman and M. J. Rand (eds.), Textbook of Pharmacology, 2nd ed., Blackwell Scientific, London, 1980, p. 33.23.

    Google Scholar 

  16. M. Sittig (ed.). Handbook of Toxic and Hazardous Chemicals and Carcinogens, 2nd ed., Noyes, NJ, 1985.

    Google Scholar 

  17. R. Spector and A. V. Lorenzo. The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicylic acid and iodide. J. Pharmacol. Exp. Ther. 188:55–65 (1974).

    Google Scholar 

  18. J. A. Cooper, P. J. Delvecchio, F. L. Minnear, et al. Measurement of albumin permeability across endothelial monolayers in vitro. J. Appl. Physiol. 62:1076–1083 (1987).

    Google Scholar 

  19. H. J. Bouman and T. B. Van Wimmersma Greidanus. A rapid and simple cannulation technique for repeated sampling of cerebrospinal fluid in freely moving rats. Brain Res. Bull. 4:575–577 (1979).

    Google Scholar 

  20. H. Benveniste and P. C. Huttemeier. Microdialysis-theory and application. Progr. Neurobiol. 35:195–215 (1990).

    Google Scholar 

  21. R. Kupferschmidt and R. W. Schmid. Specific routine determination of 3′-azido-3′-deoxythymidine (AZT) in plasma by partly automated liquid chromatography. Clin. Chem. 35:1313–1317 (1989).

    Google Scholar 

  22. H. Suzuki, Y. Sawada, Y. Sugiyama, et al. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. J. Pharmacol. Exp. Ther. 250:979–984 (1988).

    Google Scholar 

  23. T. Terasaki and W. M. Pardridge. Restricted transport of 3′-azido-3′ deoxythymidine and dideoxynucleosides through the blood-brain barrier. J. Infect. Dis. 158:630–632 (1988).

    Google Scholar 

  24. R. Spector. Drug transport in the central nervous system: Role of carriers. Pharmacology 40:1–7 (1990).

    Google Scholar 

  25. R. Yarchoan, J. M. Pluda, C. F. Perno, et al. Initial clinical experience with dideoxynucleosides as single agents and in combination therapy. Ann. N.Y. Acad. Sci. 616:328–343 (1990).

    Google Scholar 

  26. R. J. Sawchuk and M. A. Hedaya. Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. 1. Effect of probenecid. Pharm. Res. 7 (4):332–338 (1990).

    Google Scholar 

  27. M. A. Hedaya, W. F. Elmquist, and R. J. Sawchuk. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers. Pharm. Res. 7:411–417 (1990).

    Google Scholar 

  28. P. De Miranda, T. C. Burnette, and S. Good. Tissue distribution and metabolic disposition of zidovudine in rats. Drug Metab. Dis. 18:315–320 (1989).

    Google Scholar 

  29. M. A. Hedaya and R. J. Sawchuk. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit. J. Pharm. Sci. 78:716–722 (1989).

    Google Scholar 

  30. B. G. Petty, D. M. Kornhauser, and P. S. Lietman. Zidovudine with probenecid: A warning. Lancet 1044–1045 (1990).

  31. R. Spector. Thymidine transport in the central nervous system. J. Neurochem. 35:1092–1098 (1980).

    Google Scholar 

  32. R. Spector and W. G. Berlinger. Localization and mechanism of thymidine transport in the central nervous system. J. Neurochem. 39:837–841 (1982).

    Google Scholar 

  33. E. M. Cornford and W. H. Oldendorf. Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim. Biophys. Acta 394:211–219 (1975).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masereeuw, R., Jaehde, U., Langemeijer, M.W.E. et al. In Vitro and in Vivo Transport of Zidovudine (AZT) Across the Blood–Brain Barrier and the Effect of Transport Inhibitors. Pharm Res 11, 324–330 (1994). https://doi.org/10.1023/A:1018932213953

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018932213953

Navigation